focus -WSS

focus

author：entertainment 2025-09-06 01:59:50 - browse：3

U.S. Sen. Bernie Sanders sets his hands on two chairs as two people set up a board displaying a "price of drugs" chart behind him — politics coverage from STAT — Sen. Bernie Sanders has used his leadership of a Senate committee to pressure drugmakers to lower their prices. Kevin Dietsch/Getty Images

WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him.

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’s now progressed to demanding that Novo Nordisk cut its price for its novel, wildly popular diabetes and weight-loss drugs.

Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. He’s threatened subpoenas, held a prominent nominee hostage, and initiated investigations to get his way. It’s a sharp departure from the modest, bipartisan ambitions that more disciplined, discreet leaders of the committee have taken in years past, and sets the bar for how much can be accomplished using the full extent of the bully pulpit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Listen: BridgeBio's big week & Lilly's Alzheimer's data

WSS

EMA weighs against approval for Mirati's lung cancer drug

New warning issued for rebooking air travel after delays, cancellations

India sets sights on home

Stanford president to resign after investigation of research

What is the Turing Test that determines if computers can think?

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

New air purifier tech could be key to improving indoor air quality

Stanford president to resign after investigation of research

BioMarin wins approval for gene therapy to treat hemophilia A

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Virginia high school admissions case could be legal follow

EMA weighs against approval for Mirati's lung cancer drug

United colonoscopy coverage change 'may cost lives,' doctors say

New warning issued for rebooking air travel after delays, cancellations

Medical records are filled with copy

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

focus

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Researchers separate signal from noise in heart wearable data

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

'The View' co

Wikipedia

focus

explore

hotspot